Rectal cancer – pipeline review, h2 2012


Published on

2012 || Pharmaceuticals || Rectal Cancer – Pipeline Review, H2 2012 ||

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Rectal cancer – pipeline review, h2 2012

  1. 1. Rectal Cancer – Pipeline Review, H2 announces, The Latest market research report is available inits vast collection:Rectal Cancer – Pipeline Review, H2 2012RSS link of Global Markets DirectSummaryGlobal Markets Direct’s, Rectal Cancer - Pipeline Review, H2 2012, provides anoverview of the Rectal Cancer therapeutic pipeline. This report providesinformation on the therapeutic development for Rectal Cancer, complete with latestupdates, and special features on late-stage and discontinued projects. It also reviewskey players involved in the therapeutic development for Rectal Cancer. RectalCancer - Pipeline Review, H2 2012 is built using data and information sourced fromGlobal Markets Direct’s proprietary databases, Company/University websites, SECfilings, investor presentations and featured press releases from company/universitysites and industry-specific third party sources, put together by Global MarketsDirect’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Rectal Cancer.- A review of the Rectal Cancer products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  2. 2. Rectal Cancer – Pipeline Review, H2 2012therapeutics.Table of contents:List of Tables 6List of Figures 7Introduction 8Global Markets Direct Report Coverage 8Rectal Cancer Overview 9Therapeutics Development 10An Overview of Pipeline Products for Rectal Cancer 10Rectal Cancer Therapeutics under Development by Companies 12Rectal Cancer Therapeutics under Investigation by Universities/Institutes 14Late Stage Products 21Comparative Analysis 21Mid Clinical Stage Products 22Comparative Analysis 22Early Clinical Stage Products 23Comparative Analysis 23Pre-Clinical Stage Products 24Comparative Analysis 24Rectal Cancer Therapeutics – Products under Development by Companies 25Rectal Cancer Therapeutics – Products under Investigation byUniversities/Institutes 26Companies Involved in Rectal Cancer Therapeutics Development 34F. Hoffmann-La Roche Ltd. 34Abbott Laboratories 35Sanofi-Aventis 36Merck & Co., Inc. 37ImClone Systems Incorporated 38Merck KGaA 39Zenotech Laboratories Limited 40Corporacion Parc Tauli 41Isofol Medical AB 42Rectal Cancer – Therapeutics Assessment 43Assessment by Monotherapy Products 43Assessment by Combination Products 44
  3. 3. Rectal Cancer – Pipeline Review, H2 2012Assessment by Route of Administration 45Assessment by Molecule Type 47Drug Profiles 49Stimuvax - Drug Profile 49List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012 Review, H22012&PubId=&pagenum=1Myocardial Infarction – Pipeline Review, H2 2012Metastatic Liver Cancer – Pipeline Review, H2 2012Mantle Cell Lymphoma – Pipeline Review, H2 2012Malignant Mesothelioma – Pipeline Review, H2 2012Rectal Cancer – Pipeline Review, H2 2012Chemotherapy Effects – Pipeline Review, H2 2012Follicular Lymphoma – Pipeline Review, H2 2012Sleep Disorders – Pipeline Review, H2 2012
  4. 4. Rectal Cancer – Pipeline Review, H2 2012Neuroblastoma – Pipeline Review, H2 2012Cytomegalovirus (HHV-5) Infections – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: